Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction.
Kaitu'u-Lino TJ, MacDonald TM, Cannon P, Nguyen TV, Hiscock RJ, Haan N, Myers JE, Hastie R, Dane KM, Middleton AL, Bittar I, Sferruzzi-Perri AN, Pritchard N, Harper A, Hannan NJ, Kyritsis V, Crinis N, Hui L, Walker SP, Tong S. Kaitu'u-Lino TJ, et al. Among authors: kyritsis v. Nat Commun. 2020 May 15;11(1):2411. doi: 10.1038/s41467-020-16346-x. Nat Commun. 2020. PMID: 32415092 Free PMC article.
Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia.
MacDonald TM, Tong S, Myers J, Cannon P, Nguyen TV, Keenan E, Murray E, Harper A, Pritchard N, Hannan NJ, Dane KM, Middleton AL, Kyritsis VP, Walker SP, Kaitu'u-Lino TJ. MacDonald TM, et al. Among authors: kyritsis vp. Placenta. 2021 Feb;105:32-40. doi: 10.1016/j.placenta.2021.01.018. Epub 2021 Jan 22. Placenta. 2021. PMID: 33529886
Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker.
Cruickshank T, MacDonald TM, Walker SP, Keenan E, Dane K, Middleton A, Kyritsis V, Myers J, Cluver C, Hastie R, Bergman L, Garcha D, Cannon P, Murray E, Nguyen TV, Hiscock R, Pritchard N, Hannan NJ, Tong S, Kaitu'u-Lino TJ. Cruickshank T, et al. Among authors: kyritsis v. J Am Heart Assoc. 2021 Aug 17;10(16):e020302. doi: 10.1161/JAHA.120.020302. Epub 2021 Aug 13. J Am Heart Assoc. 2021. PMID: 34387117 Free PMC article.
Screening circulating proteins to identify biomarkers of fetal macrosomia.
Cruickshank T, Kaitu'u-Lino TJ, Cannon P, Harper A, Nguyen TV, Dane KM, Middleton AL, Kyritsis VP, Hastie R, Tong S, Walker SP, MacDonald TM. Cruickshank T, et al. Among authors: kyritsis vp. BMC Res Notes. 2019 Sep 18;12(1):587. doi: 10.1186/s13104-019-4625-1. BMC Res Notes. 2019. PMID: 31533811 Free PMC article.
Clinical efficacy of generic imatinib.
de Lemos ML, Kyritsis V. de Lemos ML, et al. Among authors: kyritsis v. J Oncol Pharm Pract. 2015 Feb;21(1):76-9. doi: 10.1177/1078155214522143. Epub 2014 Feb 21. J Oncol Pharm Pract. 2015. PMID: 24561549
Trastuzumab therapy in breast cancer: To reload or not to reload?
de Lemos ML, Mason K, Badry N, Kyritsis V. de Lemos ML, et al. Among authors: kyritsis v. J Oncol Pharm Pract. 2014 Aug;20(4):319-20. doi: 10.1177/1078155213506478. Epub 2013 Oct 8. J Oncol Pharm Pract. 2014. PMID: 24103899 No abstract available.